{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:14:21Z","timestamp":1792066461450,"version":"4.4.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,17]],"date-time":"2024-03-17T00:00:00Z","timestamp":1710633600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008732","name":"Uehara Memorial Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008732","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013322","name":"European Federation of Pharmaceutical Industries and Associations","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["821508"],"award-info":[{"award-number":["821508"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.ijbiomac.2024.130962","type":"journal-article","created":{"date-parts":[[2024,3,17]],"date-time":"2024-03-17T22:43:14Z","timestamp":1710715394000},"page":"130962","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"P1","title":["Metabolic effects of SGLT2i and metformin on 3-hydroxybutyric acid and lactate in db\/db mice"],"prefix":"10.1016","volume":"265","author":[{"given":"Makoto","family":"Harada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengya","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhong","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shixiang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Adam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerzy","family":"Adamski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus F.","family":"Scheerer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Neschen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin Hrabe","family":"de Angelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Wang-Sattler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2022","key":"10.1016\/j.ijbiomac.2024.130962_bb0005","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.2337\/dci22-0034","article-title":"A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of diabetes (EASD)","volume":"45","author":"Davies","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ijbiomac.2024.130962_bb0010","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.2337\/db20-0586","article-title":"Machine learning approaches reveal metabolic signatures of incident chronic kidney disease in individuals with prediabetes and type 2 diabetes","volume":"69","author":"Huang","year":"2020","journal-title":"Diabetes"},{"key":"10.1016\/j.ijbiomac.2024.130962_bb0015","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1423-0127-20-80","article-title":"Association of genetic polymorphism of PPAR\u03b3-2, ACE, MTHFR, FABP-2 and FTO genes in risk prediction of type 2 diabetes mellitus","volume":"20","author":"Abbas","year":"2013","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.ijbiomac.2024.130962_bb0020","doi-asserted-by":"crossref","first-page":"15019","DOI":"10.1038\/nrdp.2015.19","article-title":"Type 2 diabetes mellitus","volume":"1","author":"DeFronzo","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ijbiomac.2024.130962_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.130375","article-title":"Exploring novel lead scaffolds for SGLT2 inhibitors: insights from machine learning and molecular dynamics simulations","volume":"263","author":"Yu","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2024.130962_bb0030","doi-asserted-by":"crossref","first-page":"e873","DOI":"10.1016\/S2589-7500(22)00174-1","article-title":"Development of a treatment selection algorithm for SGLT2 and DPP-4 inhibitor therapies in people with type 2 diabetes: a retrospective cohort study","volume":"4","author":"Dennis","year":"2022","journal-title":"Lancet Digit. Health"},{"key":"10.1016\/j.ijbiomac.2024.130962_bb0035","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2022-002995","article-title":"Treatment pattern trends of medications for type 2 diabetes in British Columbia, Canada","volume":"10","author":"Carney","year":"2022","journal-title":"BMJ Open Diabetes Res. Care"},{"key":"10.1016\/j.ijbiomac.2024.130962_bb0040","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.021084","article-title":"Contemporary national patterns of eligibility and use of novel cardioprotective antihyperglycemic agents in type 2 diabetes mellitus","volume":"10","author":"Nargesi","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ijbiomac.2024.130962_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106667","article-title":"Neutral effect of SGLT2 inhibitors on lipoprotein metabolism: from clinical evidence to molecular mechanisms","volume":"188","author":"Osto","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ijbiomac.2024.130962_bb0050","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.2886","article-title":"Ketosis and diabetic ketoacidosis in response to SGLT2 inhibitors: basic mechanisms and therapeutic perspectives","volume":"33","author":"Qiu","year":"2017","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.ijbiomac.2024.130962_bb0055","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1210\/jc.2011-2260","article-title":"Effects of dapagliflozin on body weight, total fat mass, and regional adipose tissue distribution in patients with type 2 diabetes mellitus with inadequate glycemic control on metformin","volume":"97","author":"Bolinder","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ijbiomac.2024.130962_bb0060","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1080\/14656566.2017.1363888","article-title":"Ipragliflozin, a sodium glucose co-transporter 2 inhibitor, reduces intrahepatic lipid content and abdominal visceral fat volume in patients with type 2 diabetes","volume":"18","author":"Ohta","year":"2017","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.ijbiomac.2024.130962_bb0065","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1161\/CIRCULATIONAHA.117.029166","article-title":"Effect of Empagliflozin on the metabolic signature of patients with type 2 diabetes mellitus and cardiovascular disease","volume":"136","author":"Kappel","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.ijbiomac.2024.130962_bb0070","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.470","article-title":"Human and mouse non-targeted metabolomics identify 1,5-anhydroglucitol as SGLT2-dependent glycemic marker","volume":"11","author":"Kappel","year":"2021","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.ijbiomac.2024.130962_bb0075","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.metabol.2015.10.014","article-title":"Metformin-associated lactic acidosis: current perspectives on causes and risk","volume":"65","author":"DeFronzo","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.ijbiomac.2024.130962_bb0080","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.2337\/dc14-0464","article-title":"Incidence of lactic acidosis in patients with type 2 diabetes with and without renal impairment treated with metformin: a retrospective cohort study","volume":"37","author":"Richy","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ijbiomac.2024.130962_bb0085","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40169-017-0155-4","article-title":"Systems and precision medicine approaches to diabetes heterogeneity: a Big Data perspective","volume":"6","author":"Capobianco","year":"2017","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.ijbiomac.2024.130962_bb0090","first-page":"574","article-title":"Effects of AVE2268, a substituted glycopyranoside, on urinary glucose excretion and blood glucose in mice and rats","volume":"58","author":"Bickel","year":"2008","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.ijbiomac.2024.130962_bb0095","doi-asserted-by":"crossref","first-page":"284","DOI":"10.2337\/db14-0393","article-title":"Metformin supports the antidiabetic effect of a sodium glucose cotransporter 2 inhibitor by suppressing endogenous glucose production in diabetic mice","volume":"64","author":"Neschen","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.ijbiomac.2024.130962_bb0100","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.2337\/db16-0512","article-title":"Metformin effect on nontargeted metabolite profiles in patients with type 2 diabetes and in multiple murine tissues","volume":"65","author":"Adam","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.ijbiomac.2024.130962_bb0105","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3390\/metabo11020089","article-title":"Validation of candidate phospholipid biomarkers of chronic kidney disease in hyperglycemic individuals and their organ-specific exploration in leptin receptor-deficient db\/db mouse","volume":"11","author":"Huang","year":"2021","journal-title":"Metabolites"},{"key":"10.1016\/j.ijbiomac.2024.130962_bb0110","doi-asserted-by":"crossref","first-page":"6656","DOI":"10.1021\/ac901536h","article-title":"Integrated, nontargeted ultrahigh performance liquid chromatography\/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems","volume":"81","author":"Evans","year":"2009","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ijbiomac.2024.130962_bb0115","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1177\/0192623309336152","article-title":"Untargeted metabolomic profiling as an evaluative tool of fenofibrate-induced toxicology in Fischer 344 male rats","volume":"37","author":"Ohta","year":"2009","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.ijbiomac.2024.130962_bb0120","first-page":"141","article-title":"Metabolite profiling reveals new insights into the regulation of serum urate in humans","volume":"10","author":"Albrecht","year":"2014","journal-title":"Metabolomics Off. J. Metabolomic Soc."},{"key":"10.1016\/j.ijbiomac.2024.130962_bb0125","doi-asserted-by":"crossref","first-page":"bbab535","DOI":"10.1093\/bib\/bbab535","article-title":"TIGER: technical variation elimination for metabolomics data using ensemble learning architecture","volume":"23","author":"Han","year":"2022","journal-title":"Brief. Bioinform."},{"key":"10.1016\/j.ijbiomac.2024.130962_bb0130","first-page":"1","article-title":"Mice: multivariate imputation by chained equations in R","volume":"45","author":"van Buuren","year":"2011","journal-title":"J. Stat. Softw."},{"key":"10.1016\/j.ijbiomac.2024.130962_bb0135","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s12933-023-01862-z","article-title":"Identification of candidate metabolite biomarkers for metabolic syndrome and its five components in population-based human cohorts","volume":"22","author":"Shi","year":"2023","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.ijbiomac.2024.130962_bb0140","doi-asserted-by":"crossref","first-page":"D521","DOI":"10.1093\/nar\/gkl923","article-title":"HMDB: the human metabolome database","volume":"35","author":"Wishart","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2024.130962_bb0145","doi-asserted-by":"crossref","first-page":"D199","DOI":"10.1093\/nar\/gkt1076","article-title":"Data, information, knowledge and principle: back to metabolism in KEGG","volume":"42","author":"Kanehisa","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2024.130962_bb0150","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.cmet.2016.12.022","article-title":"Multi-dimensional roles of ketone bodies in fuel metabolism, signaling, and therapeutics","volume":"25","author":"Puchalska","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.ijbiomac.2024.130962_bb0155","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.metabol.2017.08.005","article-title":"The diabetic heart utilizes ketone bodies as an energy source","volume":"77","author":"Mizuno","year":"2017","journal-title":"Metabolism"},{"key":"10.1016\/j.ijbiomac.2024.130962_bb0160","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.cmet.2020.06.020","article-title":"SGLT2 inhibition mediates protection from diabetic kidney disease by promoting ketone body-induced mTORC1 inhibition","volume":"32","author":"Tomita","year":"2020","journal-title":"Cell Metab."},{"key":"10.1016\/j.ijbiomac.2024.130962_bb0165","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.tem.2019.01.006","article-title":"Anticatabolic effects of ketone bodies in skeletal muscle","volume":"30","author":"Koutnik","year":"2019","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.ijbiomac.2024.130962_bb0170","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/ehf2.14186","article-title":"Direct actions of dapagliflozin and interactions with LCZ696 and spironolactone on cardiac fibroblasts of patients with heart failure and reduced ejection fraction","volume":"10","author":"Ortega-Paz","year":"2023","journal-title":"ESC Heart Fail."},{"key":"10.1016\/j.ijbiomac.2024.130962_bb0175","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.cmet.2007.08.013","article-title":"Glycogen synthase kinase 3alpha-specific regulation of murine hepatic glycogen metabolism","volume":"6","author":"MacAulay","year":"2007","journal-title":"Cell Metab."},{"key":"10.1016\/j.ijbiomac.2024.130962_bb0180","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.2337\/diabetes.51.10.2903","article-title":"Effects of a novel glycogen synthase kinase-3 inhibitor on insulin-stimulated glucose metabolism in Zucker diabetic fatty (fa\/fa) rats","volume":"51","author":"Cline","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.ijbiomac.2024.130962_bb0185","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.3390\/biomedicines10112983","article-title":"Molecular mechanisms linking empagliflozin to renal protection in the LLC-PK1 model of diabetic nephropathy","volume":"10","author":"Mihaljevi\u0107","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.ijbiomac.2024.130962_bb0190","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/378785a0","article-title":"Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B","volume":"378","author":"Cross","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2024.130962_bb0195","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1016\/S0140-6736(19)31138-9","article-title":"Sarcopenia","volume":"393","author":"Cruz-Jentoft","year":"2019","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.ijbiomac.2024.130962_bb0200","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1016\/S0140-6736(17)30058-2","article-title":"Type 2 diabetes","volume":"389","author":"Chatterjee","year":"2017","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.ijbiomac.2024.130962_bb0205","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.2337\/db05-1183","article-title":"Decreased muscle strength and quality in older adults with type 2 diabetes: the health, aging, and body composition study","volume":"55","author":"Park","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.ijbiomac.2024.130962_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2023.155585","article-title":"Diet, exercise, and pharmacotherapy for sarcopenia in people with diabetes","volume":"144","author":"Hashimoto","year":"2023","journal-title":"Metabolism"},{"key":"10.1016\/j.ijbiomac.2024.130962_bb0215","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1002\/jcb.25825","article-title":"Evidence for pipecolate oxidase in mediating protection against hydrogen peroxide stress","volume":"118","author":"Natarajan","year":"2017","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.ijbiomac.2024.130962_bb0220","first-page":"548","article-title":"Metabolomic analysis of diet-induced obese mice supplemented with eicosapentaenoic acid","volume":"128","author":"Nishitani","year":"2020","journal-title":"Exp. Clin. Endocrinol. Diabetes Off. J. Ger. Soc. Endocrinol. Ger. Diabetes Assoc."},{"key":"10.1016\/j.ijbiomac.2024.130962_bb0225","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.3390\/cells10061352","article-title":"In vitro fertilisation of mouse oocytes in L-proline and L-pipecolic acid improves subsequent development","volume":"10","author":"Treleaven","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.ijbiomac.2024.130962_bb0230","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1080\/09168451.2016.1210499","article-title":"Regulatory effects of the L-lysine metabolites, L-2-aminoadipic acid and L-pipecolic acid, on protein turnover in C2C12 myotubes","volume":"80","author":"Sato","year":"2016","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.ijbiomac.2024.130962_bb0235","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.freeradbiomed.2007.10.054","article-title":"Proline modulates the intracellular redox environment and protects mammalian cells against oxidative stress","volume":"44","author":"Krishnan","year":"2008","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ijbiomac.2024.130962_bb0240","doi-asserted-by":"crossref","first-page":"508","DOI":"10.2337\/dci19-0074","article-title":"SGLT2 inhibitors produce cardiorenal benefits by promoting adaptive cellular reprogramming to induce a state of fasting mimicry: a paradigm shift in understanding their mechanism of action","volume":"43","author":"Packer","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ijbiomac.2024.130962_bb0245","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.amjmed.2020.01.016","article-title":"Does metformin interfere with the cardiovascular benefits of SGLT2 inhibitors? Questions about its role as the cornerstone of diabetes treatment","volume":"133","author":"Packer","year":"2020","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ijbiomac.2024.130962_bb0250","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3390\/jcm8010045","article-title":"Combination therapy with an SGLT2 inhibitor as initial treatment for type 2 diabetes: a systematic review and meta-analysis","volume":"8","author":"Milder","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ijbiomac.2024.130962_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2019.118635","article-title":"Crosstalks of GSK3 signaling with the mTOR network and effects on targeted therapy of cancer","volume":"1867","author":"Evangelisti","year":"2020","journal-title":"Biochim. Biophys. Acta, Mol. Cell Res."},{"key":"10.1016\/j.ijbiomac.2024.130962_bb0260","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.molcel.2018.04.024","article-title":"mTORC1 promotes metabolic reprogramming by the suppression of GSK3-dependent Foxk1 phosphorylation","volume":"70","author":"He","year":"2018","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ijbiomac.2024.130962_bb0265","first-page":"4076","article-title":"mTOR regulates brain morphogenesis by mediating GSK3 signaling","volume":"141","author":"Ka","year":"2014","journal-title":"Dev. Camb. Engl."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024017677?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024017677?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,13]],"date-time":"2024-04-13T02:26:08Z","timestamp":1712975168000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813024017677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":53,"alternative-id":["S0141813024017677"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.130962","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic effects of SGLT2i and metformin on 3-hydroxybutyric acid and lactate in db\/db mice","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.130962","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"130962"}}